Amifostine/pilocarpine - Cellix Bio

Drug Profile

Amifostine/pilocarpine - Cellix Bio

Alternative Names: CLX 156

Latest Information Update: 24 Apr 2018

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Cellix Bio
  • Class Alkaloids; Antiglaucomas; Antineoplastics; Chemoprotectants; Eye disorder therapies; Furans; Imidazoles; Miotics; Organothiophosphorus compounds; Small molecules
  • Mechanism of Action Muscarinic receptor agonists; Oxygen radical scavengers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity Yes

Highest Development Phases

  • Preclinical Presbyopia
  • Discontinued Xerostomia

Most Recent Events

  • 24 Apr 2018 Discontinued - Preclinical for Xerostomia in India (unspecified route) (Cellix Bio pipeline, April 2018)
  • 24 Apr 2018 Preclinical trials in Presbyopia in India (unspecified route), prior to April 2018 (Cellix Bio pipeline, April 2018)
  • 20 Feb 2018 Preclinical trials in Xerostomia in India (unspecified route), prior to February 2018 (Cellix Bio pipeline, February 2018)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top